The Interconnectedness of CKD, Systemic Inflammation, and ASCVD

Chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) are closely intertwined, sharing systemic inflammation as a key driver of disease progression and adverse outcomes. As evidence continues to evolve, understanding and targeting inflammation is increasingly becoming a critical component of comprehensive care for patients living with CKD who are at heightened cardiovascular risk.

This interactive digital clinical bulletin is designed to bring busy healthcare professionals up to speed on the latest research, expert guidance, and practical strategies for addressing systemic inflammation in the context of CKD and ASCVD risk. Explore how inflammation links CKD and ASCVD, and why it represents a critical—and modifiable—therapeutic target.

SCM attendees smiling at camera while attending the conference

SCM27 Registration & Abstract Submissions Open

Register early and save! Join the kidney care community at SCM27, May 11-15, 2027, in Orlando, Florida, for innovative education, practical clinical updates, research, and networking.

The Call for Scientific Abstracts is now open through December 1, 2026, offering an opportunity to showcase your research and clinical discoveries.

Learn More
Connect with Us

For Kidney Health Professionals Who Want to Stay Informed

Opt in to receive education opportunities for professionals, resources for your patients, or updates from NKF.

Information contained in this NKF educational resource is based on data available at the time of publication. It is intended to help clinicians stay informed about new scientific findings and developments. This resource is not intended to establish a preferred standard of care and should not be interpreted as prescribing an exclusive course of management.
© 2026 National Kidney Foundation, Inc.